Viewing Study NCT02265666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-28 @ 11:42 AM
Study NCT ID: NCT02265666
Status: COMPLETED
Last Update Posted: 2014-10-16
First Post: 2014-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module